293b cpd has been researched along with propafenone in 1 studies
Studies (293b cpd) | Trials (293b cpd) | Recent Studies (post-2010) (293b cpd) | Studies (propafenone) | Trials (propafenone) | Recent Studies (post-2010) (propafenone) |
---|---|---|---|---|---|
100 | 0 | 16 | 1,471 | 268 | 239 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, A; Becker, R; Busch, A; Freigang, KD; Gerlach, U; Hansen, A; Kraft, P; Kübler, W; Lang, HJ; Müller, M; Schöls, W; Senges, JC; Voss, F | 1 |
1 other study(ies) available for 293b cpd and propafenone
Article | Year |
---|---|
Rate- and site-dependent effects of propafenone, dofetilide, and the new I(Ks)-blocking agent chromanol 293b on individual muscle layers of the intact canine heart.
Topics: Animals; Anti-Arrhythmia Agents; Chromans; Dogs; Heart; Phenethylamines; Potassium Channel Blockers; Propafenone; Refractory Period, Electrophysiological; Sulfonamides | 1999 |